NCT07915895
Retroperitoneal Tumor Registry
StatusRecruiting
PhaseNot specified
Primary completion (estimated)
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 1 version: 1 with changes below.
- Study First Submitted
Endpoints
Primary
Overall Survival
Timeframe: Up to 5 years after enrollment
Sites
1 site in 1 country
- The First Hospital of Jilin UniversityChangchun, Jilin, China